<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>18661446</identifier>
<setSpec>0365-6691</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Barcia, M</dc:author>
<dc:author>De-Domingo-Barón, B</dc:author>
<dc:author>Romero-Jung, P</dc:author>
<dc:author>Rodríguez-Ares, T</dc:author>
<dc:author>Touriño-Peralba, R</dc:author>
<dc:author>Pardo-Sánchez, F</dc:author>
<dc:description xml:lang="en">CLINICAL CASE A 38-year-old man with fungal Alternaria keratitis was referred from another hospital 25 days after post-traumatic penetrating keratoplastia surgery on his right eye. We commenced treatment with topical voriconazole and the condition resolved. DISCUSSION Fungal Alternaria keratitis is rare, and treatment is difficult because the clinical response does not correlate well with the antibiotic in vitro sensitivity of the fungus. Clinical cases need to be diagnosed and treated quickly if visual loss is to be avoided. The combination of topical and systemic voriconazole has been shown to be an effective treatment for this condition</dc:description>
<dc:type>Case Reports</dc:type>
<dc:language>es</dc:language>
<dc:date>2008 Aug </dc:date>
<dc:title xml:lang="es">Uso de voriconazol tópico en queratitis por alternaria.</dc:title>
<dc:title xml:lang="en">[Use of topical voriconazole in Alternaria keratitis].</dc:title>
<dc:publisher>Archivos de la Sociedad Espanola de Oftalmologia</dc:publisher>
</metadata>
</record>
</pubmed-document>
